11/14
12:46 pm
cogt
Rating for COGT
Low
Report
Rating for COGT
11/13
05:34 am
cogt
Rating for COGT
Low
Report
Rating for COGT
11/13
05:34 am
cogt
Rating for COGT
Low
Report
Rating for COGT
11/13
12:45 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
11/13
12:45 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
11/4
08:19 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
Medium
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
10/24
08:08 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
Medium
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
10/24
05:56 am
cogt
Rating for COGT
Medium
Report
Rating for COGT
10/24
05:56 am
cogt
Rating for COGT
Medium
Report
Rating for COGT
9/24
12:01 pm
cogt
Rating for COGT
Low
Report
Rating for COGT
9/24
12:01 pm
cogt
Rating for COGT
Low
Report
Rating for COGT
9/5
07:30 am
cogt
Rating for COGT
Low
Report
Rating for COGT
9/5
07:30 am
cogt
Rating for COGT
Low
Report
Rating for COGT
9/3
10:12 pm
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock, up previously from $10.00.
Low
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock, up previously from $10.00.
9/3
10:12 pm
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock, up previously from $10.00.
Low
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock, up previously from $10.00.